Image

Anti-wandering System for People With Intellectual Disability

Anti-wandering System for People With Intellectual Disability

Recruiting
All
Phase N/A

Powered by AI

Overview

The study has 6 research questions regarding the use of the anti-wandering system in day activity centre cum hostel for persons with intellectual disabilities:

Primary study questions:

  1. Can the anti-wandering system reduce the time in seconds to turn off the alarm made by the system (a proxy measure of the response time of care staff)?
  2. Can the anti-wandering system reduce the burden of care staff on keeping track of the residents?

Secondary study questions:

3. How many alarms does the anti-wandering system generate?

4. How many false alarms does the anti-wandering system made as reported by staff?

Auxiliary study questions:

5. What are the reasons for keeping or loosening restrictions on users due to the use of the anti-wandering system?

6. What are the perceived benefits and feasibility of anti-wandering system compared to conventional anti-wandering practices?

Description

Study design

The trial is a single group pre-post test study at Haven of Hope Ming Tak Day Activity Centre and Hostel and Haven of Hope Sau Mau Ping Day Activity Centre Cum Hostel. There will be a pre-test of 4 weeks and trial of 12 weeks. During pre-test, the alarm of the anti-wandering system will be muted, and the response time in spotting participants in selected unauthorized areas without system alarm can be recorded. During the trial period, the alarm will be turned on, so that care staff will be alerted when participants enter unauthorized area.

This protocol complies with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - Guideline for Good Clinical Practice (ICH-GCP) and Declaration of Helsinki.

Procedures

  1. Participants' selection and consent

If it is feasible to install radio frequency identification (RFID) tags on all the clothes of all the residents in the study sites, all of them will be invited to participate in the trial. If this is not feasible, priority will be given to those who have higher risk in wandering (i.e. have a history of running off, attempting to leave authorized areas, or entering unauthorized areas).

Participants and their family members will be notified about the utilization of the anti-wandering system and installation of the RFID tags in participants' clothes. If they do not want to participate, they can notify the care staff (Opt-out participation).

For care staff, it will be presumed that they agree to participate in the study if they complete the anonymous questionnaire (i.e. implied consent) on that assesses the burden of care staff on keeping track of the residents. Written consent will be obtained from care staff before qualitative interview.

2. System installation

The system installation includes installing the RFID sensors in the entrances of the kitchen, laundry room, storage room, activity room and pharmacy, inserting RFID tags (size about 4cm x 1cm x 0.3cm) in the participants' clothes, and installing related software(s) in computers in the general office. The service unit and the product supplier shall discuss the installation plan.

3. 1-month pre-test

The objective of the pre-test period (Week 1 to Week 4) is to collect baseline data on the time it takes the care staff to spot a resident who has entered an unauthorized area. During the pre-test period, the alarm of the anti-wandering system will be muted. Existing anti-wandering measures will be maintained, including locking unauthorized areas, setting up carts or barriers at the entrance of the unauthorized areas, having staff stay in the unauthorized areas when the doors of the areas are open, and forbidding residents hanging around during certain time of the day. When care staff spots a resident in an unauthorized area, he or she will reset the anti-wandering system and then return the resident to a safe place. During the process, the system will record the response time of the care staff without system alarm. Reminders on contacting the general office staff to reset the anti-wandering system will be posted in unauthorized areas.

4. Training for care staff

A few identical 1-hour training sessions will be provided to care staff. The supplier will instruct and demonstrate to care staff how to use the anti-wandering system. The University of Hong Kong (HKU) researcher will then explain the test flow and data collection. This training will be recorded so that care staff can re-watch it. A protocol with related operations will be provided to care staff.

5. Implementation

During the testing period, the system will promptly notify care staff if a participant enters unauthorized areas (e.g. the speaker installed at the hallway and monitor at the general office will broadcast and display the bed number of the participant and their position). A care staff will then go to that area and search for the participant. After the participant is found, care staff will contact the staff in the general office to reset the system, and then return the participant to a safe place. At the end of each shift, care staff will document any abnormal events, as determined by the care staff, during the use of the new anti-wandering system in a log book. HKU researcher will analyze the record to determine whether the alarm generated by the system is false or not. This experience will be used to revise the operation protocol.

Blinding

No blinding will be done for this single group study.

Sample size determination

The number of residents is estimated by the number of the residents residing in the study sites. The number of care staff is estimated by the number of related staff working in the study sites. It is expected that 40 residents and 20 care staff will be recruited.

Data analyses

  1. Main analysis

Independent sample t-test will be used to test the difference of the response time and the anonymous data of care staff burden (including the perceived frequency of giving residents freedom of movement, feeling guilt in restricting residents, having conflicts with residents due to restricting them, and worrying residents to enter unauthorized areas unsupervised) between pre-test (from Week 1 to Week 4) and main trial (from Week 5 to Week 16). Descriptive statistics will be used to examine whether the care staff have more time to handle other duties and whether they can better concentrate on other duties.

2. Process evaluations

The number of alarms generated by the system, the number of false alarms reported by care staff, and the number of missing person report will be counted. False alarm rate will be calculated by dividing the number of false alarms by the total number of alarms.

The reasons for keeping or loosening restrictions on users due to the use of the anti-wandering system will be summarised.

3. Qualitative interview

The interview content will be transcribed verbatim in Chinese for further analysis. The qualitative interview transcripts will be analyzed by using framework analysis to construct a coherent and logical structure from the classification of many opinions and perceptions of the anti-wandering system. The results will then be discussed and consolidated in the panel meetings with the co-authors.

Eligibility

Inclusion Criteria:

Inclusion criteria of residents:

• Residents of the study sites

Inclusion criteria of care staff:

• Responsible for the operation of the anti-wandering system

Exclusion Criteria:

Exclusion criteria of residents:

• Not independently mobile (i.e. unable to walk around without care staff assistance)

Exclusion criteria of care staff:

• Nil

Study details
    Technology

NCT05785702

The University of Hong Kong

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.